Layer 1

Non-vitamin K antagonist oral anticoagulants

Non-vitamin K antagonist oral anticoagulants

From this CPD module you will learn about:

  • The conditions that NOACs are indicated for
  • The advice you should give if patients forget to take a dose or take too much
  • Safety aspects and interactions for NOACs
  • The recommended process for switching from warfarin to a NOAC and vice versa

Download a printable PDF of this module – including the five-minute test – here.

There are four non-vitamin K antagonist oral anticoagulants (NOACs) – apixaban (Eliquis), dabigatran etexilate (Pradaxa), edoxaban (Lixiana) and rivaroxaban (Xarelto).(1-4) Unlike warfarin, which works by inhibiting clotting factors that are dependent on vitamin K, the majority of NOACs act by inhibiting factor Xa (a protein that converts prothrombin to the key clotting factor thrombin). This then prevents the development of a clot. One

Want to read more?

Subscribe to Update Plus to continue reading our CPD content

Got an Update Plus subscription?

Why Buy Update Plus

Update Plus

In-depth clinical modules with a bespoke CPD write-up

Practical approach

Pharmacy-based clinical scenarios ask "what would you do?" and provide expert advise


Top up your clinical and practical knowledge on-the-go with our downloadable podcasts

Picture quiz

Use of interactive picture quiz to refresh your knowledge of various conditions

Not subscribed yet?

Buy Update Plus today

Job of the week

Pharmacy Dispenser
Feltham, London (Greater)